RecruitingNot ApplicableNCT05724641

Arterial Spin Labeling MRI for Assessing Blood Perfusion in the Human Eye Repeatability Study and Clinical Application


Sponsor

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Enrollment

70 participants

Start Date

Jan 10, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

The MRI perfusion imaging using arterial spin labeling (ASL)'s non-invasive technique (i.e. without injection of contrast medium) allows, thanks to recent technological improvement of the spatial resolution, measuring several perfusion parameter of the retinal tissue such as the regional Blood Flow (rBF) or the cerebral blood flow (cBF) expressed in ml/100g/min. Reliable application of ASL thus requires the precision and specificity of the MRI protocol to be tested.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying MRI perfusion imaging using ASL's non-invasive technique for people with retinal diseases. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTMRI perfusion imaging using ASL's non-invasive technique

Patients will undergo through an MRI-scan using the ASL MRI sequence, as described per protocol.


Locations(1)

Cliniques Universitaires Saint Luc

Brussels, Brussels Capital, Belgium

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05724641


Related Trials